Absolute lymphocytes count ?  cells/mm
Prior ACT infusion within  months of study enrollment (cohorts include ACT with tumor infiltrating lymphocytes [TIL], human leukocyte antigen [HLA]-class I T cell receptor [TCR]-engineered lymphocytes, HLA-class II TCR-engineered lymphocytes, and chimeric antigen receptor [CAR]-engineered T cells)
Planned preemptive/prophylactic administration of donor lymphocytes (as per section ..)
Lymphocytes* ? /mm (? . x ^/L)
Lymphocytes >= /mcL
Lymphocytes ?  / mcL within  days of treatment initiation
Absolute lymphocytes count >= /mcL
Absolute Lymphocytes ?/uL
Lymphocytes ? . x /L
Lymphocytes >= /mm^
Lymphocytes >= . x ^/L
Donor lymphocytes available or able to be collected
Unlikely to be able to procure additional donor lymphocytes
Lymphocytes >= /mm^
Lymphocytes < % of total white blood cells (WBCs) at baseline
Total lymphocytes count ? .xE/L
Absolute lymphocytes > /mcL
Lymphocytes > / mm